Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Issued: 2022-2024

Historic Shares Issued for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $15.0 million.

  • Orchestra BioMed Holdings' Shares Issued rose 405.56% to $91,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $15.1 million, marking a year-over-year increase of 6228.87%. This contributed to the annual value of $15.0 million for FY2024, which is 6408.66% up from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Shares Issued stood at $15.0 million for FY2024, which was up 6,408.66% from $231,000 recorded in FY2023.
  • Orchestra BioMed Holdings' Shares Issued's 5-year high stood at $15.0 million during FY2024, with a 5-year trough of $121,000 in FY2022.
  • Moreover, its 3-year median value for Shares Issued was $231,000 (2023), whereas its average is $5.1 million.
  • Data for Orchestra BioMed Holdings' Shares Issued shows a peak YoY surged of 6,408.66% (in 2024) over the last 5 years.
  • Orchestra BioMed Holdings' Shares Issued (Yearly) stood at $121,000 in 2022, then skyrocketed by 90.91% to $231,000 in 2023, then spiked by 6,408.66% to $15.0 million in 2024.